CBC-PAM 500MG/20ML Pralidoxime

CBC-PAM 500MG/20ML Pralidoxime

Product Details:

  • Drug Type Injection
  • Physical Form Liquid
  • Dosage 500 Mg
  • Suitable For Adults
  • Supply Ability : 100000 , Per Week
  • Click to view more

Price And Quantity

  • 775 INR
  • 100000 ,

Product Specifications

  • Adults
  • Injection
  • 500 Mg
  • Liquid

Trade Information

  • Cash in Advance (CID), Cash Advance (CA)
  • 100000 , Per Week
  • 1 Week
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

Product Description

CBC -Pam - CBC -Pam is an antidote, prescribed for organo phosphorous poisoning. Indications: CBC -Pam is an antidote, prescribed for organophosphorous poisoning. But is not effective as an antidote for all types of pesticide poisonings. Contraindications: Contraindications in patients with known hypersensitivity to the drug and Carbamate pesticide poisoning. Dosage: Adult: IV/IM- Used in combination with atropine. The recommended dose is 1-2 g, repeat dose after 1 hour, then 8-12 hourly if needed. Usage: It comes as a solution for injection to be administered by a healthcare provider into the vein, muscle or under the skin. Precautions: Caution should be exercised in patients with history of myasthenia gravis, kidney disease, during pregnancy and breastfeeding. Monitor breathing, blood pressure, oxygen levels, kidney function regularly while taking CBC -Pam. It may cause drowsiness, blurred vision, or dizziness, do not drive a car or operate machinery while taking CBC -Pam. Side Effects: Most Common - Blurred vision, double vision, impaired accommodation, dizziness, headache, drowsiness, nausea, muscle weakness, and fast heart rate. Warning: Avoid excess dosage. Storage Conditions: Store it at room temperature (20°-25°C). Active ingredients: Pralidoxime


* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Developed and Managed by Infocom Network Ltd.(Terms of Use)
Developed and Managed by Infocom Network Ltd.